Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
29.69
+0.07 (0.24%)
At close: Feb 27, 2026, 4:00 PM EST
29.85
+0.16 (0.54%)
After-hours: Feb 27, 2026, 7:50 PM EST
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.76 billion as of February 27, 2026. Its market cap has increased by 63.55% in one year.
Market Cap
1.76B
Enterprise Value
1.28B
1-Year Change
63.55%
Ranking
Category
Stock Price
$29.69
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.76B, an increase of 80.90%. That is a compound annual growth rate of 21.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.76B | 92.79% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 1.80B |
| Galecto | 1.79B |
| RAPT Therapeutics | 1.79B |
| Zymeworks | 1.78B |
| Tyra Biosciences | 1.77B |
| Innoviva | 1.76B |
| Agios Pharmaceuticals | 1.76B |
| Palvella Therapeutics | 1.76B |